Australia's BCAL Diagnostics sees worst day in 10 months on discounted stock placement

BCAL Diagnostics

03/06/2024 02:32

** Shares of BCAL Diagnostics  BDX.AX  fall as much as 25.7%
to A$0.130, recording its worst day since August 4, 2023
    ** Medical equipment supplier received firm commitments to
raise A$10.5 mln($6.99 mln) at A$0.10 per new share
    ** Offer price represents discount of 42.9% to last day's
close
    ** Around 1.0 mln shares change hands, compared with the
30-day average volume of 336,104 shares
    ** Stock has risen 76.8% this year, as of last close


($1 = 1.5020 Australian dollars)

 (Reporting by Shivangi Lahiri in Bengaluru)
 ((shivangi.lahiri@thomsonreuters.com))